HALO
Halozyme Therapeutics, Inc. · Healthcare
Director Bernadette Connaughton sold $108K of Halozyme Therapeutics, Inc.
Sold$107,591
$66.21Price
1,625Shares
−4%Stake
What HALO did after the filing
- The stock from Wed, Jun 3 open, $66.00
- +17.9%
- S&P 500, same days
- −2.0%
Measured over 30 trading days, to the Jul 17 close.
Traded Mon, Jun 1. Filed Tue, Jun 2, 5:20 PM ET, after the close. Returns use the Jun 3 open and the Jul 17 close. Not investment advice.